AImitari MedTech provides AI‑driven, non‑invasive point‑of‑care diagnostic tools for diabetes and cardiovascular diseases, using a portable 12‑channel ECG and cloud‑based analysis to deliver real‑time results with about 95% accuracy. The platform offers standardized data, personalized treatment insights, and remote clinician access, enabling clinics and telehealth providers to perform affordable diagnostics without laboratory infrastructure.
Funding
Funding not disclosed
Founders
Product
Problem
Access to accurate, timely diagnostics for diabetes and cardiovascular diseases is limited by expensive, invasive equipment and fragmented data interpretation, especially in low-resource or remote settings.
Solution
AImitari MedTech offers AI‑driven, non‑invasive diagnostic tools that deliver point‑of‑care assessments for diabetes and cardiovascular conditions. The platform uses real‑time data analysis from portable devices, such as a 12‑channel ECG system, to generate precise diagnostic results with an reported 95% accuracy rate. AI algorithms standardize and enhance data quality, providing personalized insights that support treatment decisions without the need for laboratory infrastructure. By delivering cost‑effective, cloud‑enabled solutions, the company enables scalable deployment across diverse healthcare environments, improving accessibility and reducing overall diagnostic costs.
Target Audience
Primary customers are clinics, hospitals, and telehealth providers seeking affordable, point‑of‑care diagnostic capabilities for diabetes and cardiovascular disease management, particularly in underserved or remote regions.
Features
- Portable 12‑channel ECG and telemedicine system that captures and transmits cardiac data as easily as measuring blood pressure
- AI-powered analysis engine that delivers real‑time, high‑accuracy diagnostic results for both diabetes and cardiovascular markers
- Non‑invasive measurement methods that eliminate the need for blood draws or complex lab equipment
- Personalized treatment recommendations generated from integrated patient data and predictive models
- Cloud‑based platform that standardizes data across sites, ensuring consistent quality and enabling remote clinician access
- Scalable architecture designed for global deployment in varied clinical and community settings